Momenta Pharma
(MNTA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2009 | 12-2008 | 09-2008 | 06-2008 | 03-2008 | |
| Sales | 3,990 | 2,941 | 3,914 | 3,563 | 4,152 |
| Gross Profit | 3,990 | 2,941 | 3,914 | 3,563 | 4,152 |
| Operating Expenses | 22,092 | 21,577 | 20,357 | 19,264 | 18,694 |
| Operating Income | -18,102 | -18,636 | -16,443 | -15,701 | -14,542 |
| Interest Expense | 162 | 176 | 191 | 207 | 224 |
| Other Income | 359 | 442 | 675 | 938 | 1,428 |
| Pre-tax Income | -17,905 | -18,370 | -15,959 | -14,970 | -13,338 |
| Net Income Continuous | -17,905 | -18,370 | -15,959 | -14,970 | -13,338 |
| Net Income | $-17,905 | $-18,370 | $-15,959 | $-14,970 | $-13,338 |
| EPS Basic Total Ops | -0.46 | -0.50 | -0.45 | -0.42 | -0.37 |
| EPS Basic Continuous Ops | -0.46 | -0.51 | -0.45 | -0.42 | -0.37 |
| EPS Diluted Total Ops | -0.46 | -0.50 | -0.45 | -0.42 | -0.37 |
| EPS Diluted Continuous Ops | -0.46 | -0.51 | -0.45 | -0.42 | -0.37 |
| EBITDA(a) | $-17,184 | $-17,773 | $-15,721 | $-15,231 | $-14,285 |